![David Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
David Perry worked as Senior Director-Business Development at Sangamo Therapeutics, Inc. Mr. Perry worked as Vice President-Business Development at Aligos Therapeutics, Inc. from 2024 to 2025.
Mr. Perry completed undergraduate education at Tufts University.
Former positions of David Perry
| Companies | Position | End |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 31/10/2025 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of David Perry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
- Stock Market
- Insiders
- David Perry
